Pooled retrospective analysis of 70 mg erenumab in episodic and chronic migraine: a two tertiary headache centers experience during clinical practice - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34406609/
Erenumab is a monoclonal antibody, targeted against the calcitonin gene-related peptide (CGRP) receptor. Clinical studies have demonstrated prophylactic efficacy in both episodic (EM) and chronic migraine (CM). The aim of...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrThis confirms other previous studies which is great to see.
-
Migraine Connect4yrKey Points • Conclusion: “This study shows the effectiveness of 70 mg erenumab treatment in previously therapy-refractory migraine patients under real-life conditions at two independent headache centers.” • In this retrospective study, Show More
Are PROMs passing the message? A reflection with real-life migraine patients.
Source : https://europepmc.org/article/med/34407643
Background Several patient-reported outcome measures are available to monitor headache impact, but are those reliable in real-life clinical practice? Methods Two identical patient-reported outcome measures (HALT-90 and MIDAS) were applied...
-
Migraine Connect4yrThanks for contributing, [~Huma--Sheikh--huma927@ ] ! What patient-reported outcomes do you find particularly useful? What outcomes are less useful?
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrSo important to keep in mind what patients are looking to get out of therapy.
Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trial.
Source : https://europepmc.org/article/med/34404270
Objective Identify preventive medication treatment response trajectories among youth participating in the Childhood and Adolescent Migraine Prevention study. Methods Data were evaluated from 328 youth (ages 8-17). Childhood and Adolescent...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrThis is great, there are not a lot of studies for treatments in children.
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrThe gut brain axis is so crucial.
Show More Comments
Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34407654/
1 The Saul R. Korey Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. 2 Mayo Clinic, Phoenix, AZ, USA. 3 California Medical Clinic for Headache, Santa Monica,...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrThere is now more and more evidence regarding this, great to hear there are positive results.